Answer
Pirtobrutinib (Jaypirca) should not be used during pregnancy because it can cause foetal harm; there are no data in pregnant women, and animal studies have shown reproductive toxicity.
Sources for this answer
- Jaypirca 50mg, 100mg film-coated tabletsEli Lilly and Company Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked